Cough receptor sensitivity (CRS) is increased in adults with cough-variant asthma 4 Background -Cough is a major symptom in some children with asthma. The re-but the relationship between the frequency of cough and CRS is unknown. The relationship lationship between cough and the severity of asthma is ill defined. A study was under-between CRS and airway calibre is also unknown in those who cough as a major symptom taken to test the hypotheses that, in children with asthma who cough as a major of their asthma exacerbations. During the nonacute phase of asthma CRS is not increased
(C5). In our laboratory the single de- Cth and C5 values are lower.
Clinical URTI, n (%) 10 (67) 10 (63) Virus identified, n (%) 2 (13) 1 (6) Functional severity score, median (IQR) 3 (2) 2.5 (2) Nocturnal cough, median (IQR) 2 (1) 1 (2) Exercise limitation, median (IQR) 2 (2) 1 (1)
 
Days before test, median (IQR) * 1 (1) 1 (1)
ASS and FSS values between groups were
Asthma severity score (1), median (IQR) † 6 (3) 6 (2) Asthma severity score (2), median (IQR) † 2 (1) 2 (2) compared using the 2 test. Normality of dis-FEV 1 % pred before capsaicin, median (IQR) 87 (20) 79 (30) tribution was examined using Shapiro-Wilks ised for comparing CRS measures during the * Days before test=days in hospital before tests were performed. † Asthma severity score (1)=score on admission; asthma severity score (2)=score at time of acute and non-acute periods. Spearman's rank testing.
correlation (r S ) was used to correlate CRS and
The groups did not differ in any variable using the 2 test.
FEV 1 . A two-tailed p value of < 0.05 was considered significant. Means (95% CI) are expressed as mean (CI) of log transformed data and at the time of testing was graded on the asthma severity score (ASS), 10 a scoring system unless otherwise specified. Repeatability of the question associating the child's cough with based on the total score of three items (rhonchi, accessory muscle use, and heart rate), each asthma episodes was determined using the Kappa ( ) value. 13 FEV 1 measurements are scored 0-3.
Spirometric tests (Masterlab, Jaeger, Ger-expressed as percentage predicted values. many) were performed before and after the capsaicin CRS test on the day of, or the day before, discharge. Spirometric testing was per-Results
Thirty one children were recruited (15 during formed in the upright seated position with a nose clip and the best of three attempts was January to March and 16 during August to October). The clinical profile of the children recorded. The children were tested 30-60 minutes before the administration of their sched-is shown in table 1. There was no significant difference between the groups in age, smoke uled salbutamol nebulisation. Nasopharyngeal secretions were tested for the presence of exposure, clinical upper respiratory tract infections, use of preventative medications, FSS, viruses by immunofluorescence and culture during the acute admission. The specimens frequency of nocturnal cough or exercise limitation, FEV 1 , or the severity of asthma on were processed by the virology laboratory in our hospital and cultured on three cell lines presentation (ASS) and at the time of testing.
Twenty children (64.5%) had clinical upper (human fibroblast (HuFb), monkey kidney (LLC), and tumour (HeLa)). The tests (cap-respiratory tract infection but a virus was identified in only three (15%) of these children. saicin CRS test, before and after spirometry) were repeated 7-10 days later and 4-6 weeks later in a subgroup of children.
Formal written consent was obtained and the study was approved by the hospital's ethics committee for human research.
    () 
We have previously described a method of performing the capsaicin CRS test in children that has good repeatability. 11 Briefly, capsaicin (Sigma-Aldrich, Australia) diluted in 20% alcohol was delivered through a nebuliser controlled by a dosimeter (MB3, MEFAR, Italy) in an arrangement that allowed regulation of the inspiratory flow. The dosimeter was set at 0.7 seconds inhalation time and normal saline and diluent controls were given before There was excellent agreement ( =0.75) be-as a major symptom when compared with those who do not usually cough with their asthma tween the reporting by parents of cough in association with asthma episodes on the two exacerbations. Following the resolution of the acute asthma phase, this heightened CRS reoccasions.
During the acute episode Cth and C5 in the turns to a level similar to that of children with asthma who do not usually cough. We have group who coughed were significantly lower (representing higher CRS) than in those with-also shown that there was no correlation between CRS and airway calibre as measured by out a cough (fig 1) . The mean difference between the two groups was 0.77 mol (95% CI FEV 1 in either group.
The severity of the cough is not related to 0.35 to 1.18) for Cth and 0.72 mol (95% CI 0.26 to 1.18) for C5. When tested during the measures of airway calibre in subjects with asthma. 1 14 However, in questionnaires cough non acute phases 7-10 days and 4-6 weeks after the acute presentation there was no difference alone is often used as a symptom of the stability of asthma. 2 3 In children the frequency of nocbetween the groups (fig 2) . In the group that coughed the difference in CRS between the turnal cough in the recovery phase of acute severe asthma does not correlate with the clinacute and non-acute episode (day 7-10) was significant (mean difference in Cth 0.49 mol ical severity of asthma, nor to airway calibre measured by peak flow in its absolute values (95% CI 0.13 to 0.85), p=0.01; mean difference in C5 0.52 mol (95% CI 0.28 to 0.76), or its variability. 1 Hsu and colleagues showed that, in adults with non-acute asthma, the frep=0.008). There was no significant difference between the two phases of asthma in the non-quency of cough measured objectively (with an ambulatory cough meter) had no relationship coughing group (mean difference in Cth −0.10 mol (95% CI −0.43 to 0.23) and in to asthma severity measured by FEV 1 and diurnal peak flow variation. 14 Could heightened C5 0.19 mol (95% CI −0.10 to 0.45)). CRS was not significantly different between the CRS account for these patients with asthma who have troublesome coughing? Asthma in groups based on the presence of clinical or culture proven viral infection.
children is known to be a variable disorder and it has been questioned as to whether it is a FEV 1 did not change after capsaicin inhalation (table 1) . CRS did not correlate with FEV 1 single disorder or a whole variety of different pathological processes that result in a common in either the group that coughed (r S =−0.08 for Cth; r S =0.03 for C5) or the group that did feature which is airways obstruction that varies from time to time. 15 The results of this study not cough (r S =0.11 for Cth; r S =−0.19 for C5). The change in CRS between the acute suggest that a subset of children with asthma develop heightened cough receptor sensitivity (day 1) and non-acute (7-10 days later) phase for both groups did not correlate with the during acute exacerbations while others do not.
This may be associated with the severity of change in FEV 1 between the two test days. The change in FEV 1 between the acute and non-the inflammation as the pathophysiology of coughing in asthma is likely to be related to acute phase for the children who coughed was not significantly different from the children the inflammatory process. 16 17 However, we did not measure any marker of inflammation and who did not cough (mean difference between coughers and non-coughers=−18.5% (95% cannot substantiate this possibility. Fujimura et al recently showed that indomethacin and CI −43.3 to 6.2).
OKY-046 (a thromboxane synthesis inhibitor) significantly altered the capsaicin cough threshold in adults with asthma, but not in normal Discussion This study has shown that, during an acute controls, and suggested that cyclooxygenase products alter CRS in inflammatory airway severe exacerbation of asthma, CRS is heightened in children with asthma who cough diseases. 17 Another possible explanation why group.bmj.com on October 11, 2017 -Published by http://thorax.bmj.com/ Downloaded from a subset of children with asthma develop a exacerbation of asthma. 23 The subjects in our study, who were all admitted to hospital for heightened CRS during an acute episode could be related to the different response of some their asthma with severe wheeze and dyspnoea, are considerably different from the children of individuals to a specific stimulus, similar to aspirin sensitivity in a subset of patients with that community study 23 whose asthma exacerbations were identified by changes in peak asthma. 18 Patients with aspirin-sensitive asthma are known to have a different response to as-expiratory flow, which has many pitfalls. 24 Furthermore, the carriage rate of the virus type pirin, possibly from altered target organ sensitivity, which results in increased release of identified by PCR during the asymptomatic phase of that group of children was not recysteinyl leukotrienes and eosinophil degradation. 18 In a recent editorial Hills suggested ported. 23 The culture techniques of our laboratory cannot identify several viruses associated that, in the airways of patients with asthma, the breakdown of the natural physical barrier with the common cold -namely, coronavirus and reovirus. 9 However, we believe that our of surfactant -thus unmasking receptors -may contribute to the pathophysiology of asthma. 19 low rate of viral identification did not alter our findings because (1) there was an equal number Minor qualitative or quantitative deficiencies in surfactant could be present in children who of clinical upper respiratory tract infections in each group (10 in each group), (2) when the cough with their asthma episodes. Surfactant deficiency has been shown in the upper airways children were grouped based on upper respiratory tract infection (present or absent) there of adults with asthma. 19 Perhaps just as children with cystic fibrosis may have predominantly was no significant difference in CRS between the two groups, and (3) the clinical diagnosis pulmonary or gastrointestinal complications (or both) which cannot be entirely explained of upper respiratory tract infection was made prior to the knowledge of the viral studies and by genotype difference, children with asthma may predominantly have cough or wheeze or cough group.
We conclude that, in children with asthma, both. All these explanations are, however, speculative and we do not have data to support CRS is heightened during the acute severe phase in the subgroup of children who cough them, but further research into why a subgroup of children with asthma are coughers would with their asthma episodes. CRS decreases to levels similar to children with asthma who do shed some light on the common paediatric problem of coughing.
not have troublesome coughing within 7-10 days and does not correlate with FEV 1 . Altered Several groups have shown the independence of CRS and bronchomotor tone in the laborat-sensitivity of cough receptors during an acute exacerbation may be a reason why some chilory.
6-8 These studies were performed in adults 
